197 related articles for article (PubMed ID: 5587456)
21. [Ataractic treatment in psychiatry and general medicine. Review of preparations. 9].
Hertrich O
Fortschr Med; 1983 Oct; 101(40):1828-30. PubMed ID: 6642389
[No Abstract] [Full Text] [Related]
22. A clinical trial of EXP 338 in the treatment of a neurotic population.
Claghorn JL; Schoolar JC
Curr Ther Res Clin Exp; 1968 Jun; 10(6):279-81. PubMed ID: 4969833
[No Abstract] [Full Text] [Related]
23. Treatment of psychoneurosis.
Br Med J; 1968 May; 2(5600):288-9. PubMed ID: 5646543
[No Abstract] [Full Text] [Related]
24. Clinical pharmacology of psychotropic drugs.
Ban TA
Appl Ther; 1967 Apr; 9(4):366-71. PubMed ID: 6039139
[No Abstract] [Full Text] [Related]
25. The value of drugs in the treatment of neuroses.
HUTCHINSON JT
Med Illus; 1956 Aug; 10(8):541-4. PubMed ID: 13358407
[No Abstract] [Full Text] [Related]
26. [Experience with the new tranquilizing agent Wy 4036 (lorazepam) in the specialties psychiatric neurology and internal medicine].
Leube H; Höffkes H
Arzneimittelforschung; 1971 Jul; 21(7):1098-102. PubMed ID: 5109550
[No Abstract] [Full Text] [Related]
27. [Treatment of neuroses].
Nishizono M
Saishin Igaku; 1965 Sep; 20(9):2480-6. PubMed ID: 5887228
[No Abstract] [Full Text] [Related]
28. [Preliminary clinical trials a new benzodiazepine tranquilizing agent: Temazepan (ER-115)].
Madalena JC; Matos HG
Hospital (Rio J); 1970; 78(5):1417-23. PubMed ID: 4934891
[No Abstract] [Full Text] [Related]
29. [Editorial: Time to take tranquilizers under reconsideration].
Lakartidningen; 1974 Nov; 71(46):4591. PubMed ID: 4427488
[No Abstract] [Full Text] [Related]
30. [Use of a new thioxanthene in psychiatry].
Campos Jde S; Delgado JA
Hospital (Rio J); 1968 May; 73(5):1619-25. PubMed ID: 5308762
[No Abstract] [Full Text] [Related]
31. The chronic emotionally disturbed patient: an efficient management model.
Stevenson JM
W V Med J; 1973 Apr; 69(4):83-4. PubMed ID: 4512208
[No Abstract] [Full Text] [Related]
32. [Double-blind study of the use of Nobrium in ambulatory therapy].
Pasini E
Riv Sper Freniatr Med Leg Alien Ment; 1970 Jun; 94(3):726-55. PubMed ID: 5517401
[No Abstract] [Full Text] [Related]
33. [Possibilities of therapeutic control of exhaustion states and psychoneurotic disorders].
Michalová C
Psychiatr Neurol Med Psychol (Leipz); 1965 Jun; 17(6):225-32. PubMed ID: 4378600
[No Abstract] [Full Text] [Related]
34. [Clinical evaluation of mesoridazine(NC 123) Sandoz].
Bilikiewicz A; Dolmierski R
Psychiatr Pol; 1967; 1(4):455-8. PubMed ID: 4875480
[No Abstract] [Full Text] [Related]
35. [Chlorpromazine and tranquilizing agents; psychotherapeutic incidences].
HELD R
Encephale; 1956; 45(4):1000-4. PubMed ID: 13384333
[No Abstract] [Full Text] [Related]
36. [Experience with applying the benzquinamid preparation in psychoneurological practice].
Borts MI; Vovin RIu; Nemchin TA
Vopr Psikhiatr Nevropatol; 1966; 12():467-75. PubMed ID: 6014508
[No Abstract] [Full Text] [Related]
37. [Anxiety, upbringing and psychopharmaca. Biopsychological observations].
Arnfred AH
Ugeskr Laeger; 1968 Nov; 130(48):2065-7. PubMed ID: 5707926
[No Abstract] [Full Text] [Related]
38. Prazepam in the treatment of anxiety and tension: a clinical study of a new benzodiazepine derivative.
Kingstone E; Villeneuve A; Kossatz I
Curr Ther Res Clin Exp; 1966 Apr; 8(4):159-63. PubMed ID: 4956321
[No Abstract] [Full Text] [Related]
39. Controlled study of the effects of tybamate on the neurotic component in dermatoses.
Shapiro I
Curr Ther Res Clin Exp; 1966 Mar; 8(3):99-105. PubMed ID: 4956583
[No Abstract] [Full Text] [Related]
40. [Clinical experimentation with a new benzodiazepinic: temazepan].
Sokolovsky A; de Litvac AM; Corrêa RS; Ramadam ZB
Hospital (Rio J); 1970 Aug; 78(2):545-57. PubMed ID: 5313032
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
